Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH1175448666
Tue, 21.02.2023
Straumann Holding AG
Full-year revenue climbs organically by 15.7% and reaches CHF 2.3 billion
Fourth quarter revenue reached CHF 592 million with organic growth of 9.6%
Core EBIT margin of 26% while core net profit rose to CHF 482 million
Engagement score of 81 and target to achieve net zero carbon emissions by 2040
Board proposes further dividend increase to CHF [ … ]
Wed, 02.11.2022
Straumann Holding AG
Third-quarter revenue amounts to CHF 551 million, an increase of 12%, bringing revenue in the first nine months of 2022 to CHF 1.7 billion
All regions performing well with LATAM leading organic growth with 21%
Roxolid SLActive study highlights preclinical premium implant outcome
ClearCorrect received regulatory approval in China
Investment in [ … ]
Wed, 02.11.2022
Straumann Holding AG
Third-quarter revenue amounts to CHF 551 million, an increase of 12%, bringing revenue in the first nine months of 2022 to CHF 1.7 billion
All regions performing well with LATAM leading organic growth with 21%
Roxolid SLActive study highlights preclinical premium implant outcome
ClearCorrect received regulatory approval in China
Investment in [ … ]
Tue, 16.08.2022
Straumann Holding AG
Half-year revenue reached CHF 1.2 billion, growing 21% organically
Revenue increased by 15.1% to reach CHF 589 million in the second quarter
Strong volume growth brought core EBIT to CHF 329 million, with a margin of 27.9%
Reported net profit rose to CHF 265 million or 23%
Further development of the doctor-led clear-aligner treatment solutions [ … ]
Tue, 16.08.2022
Straumann Holding AG
Half-year revenue reached CHF 1.2 billion, growing 21% organically
Revenue increased by 15.1% to reach CHF 589 million in the second quarter
Strong volume growth brought core EBIT to CHF 329 million, with a margin of 27.9%
Reported net profit rose to CHF 265 million or 23%
Further development of the doctor-led clear-aligner treatment solutions [ … ]